Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus

Journal of Clinical Epidemiology

Volumn 55, Issue 4, 2002, Pages 345-349

  Erkens, Joëlle A ^a,b   Herings, Ron M C ^a   Stolk, Ronald P ^b   Spoelstra, José A ^a,b   Grobbee, Diederick E ^b   Leufkens, Hubert G M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

diabetes mellitus, cardiovascular drugs, case control study, epidemiology, prevalence

Indexed keywords

ACARBOSE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; BIGUANIDE DERIVATIVE; CARDIAC AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; LOOP DIURETIC AGENT; METFORMIN; SULFONYLUREA; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036128053     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00482-6     Document Type: Article

References (29)

1. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
2. Banting lecture 1988. Role of insulin resistance in human disease
3. NIDDM and its metabolic control predict coronary heart disease in elderly subjects
4. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men
5. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults
6. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life
7. A chronic disease score from automated pharmacy data
8. Assessment and control for confounding by indication in observational studies
9. A pharmaceutical profile of diabetic patients
10. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
11. High blood pressure and the incidence of non-insulin dependent diabetes mellitus; findings in a 11.5 year follow-up study in The Netherlands
12. Impact of cardiovascular disease on health care utilization in a defined diabetic population
13. Costs and effectiveness of medications in diabetes patients
14. Impaired glucose tolerance in the U.S. population
15. Diabetes and cardiovascular disease. The 'common soil' hypothesis
16. Cardiovascular disease risk factors as predictors of type 2 (non- insulin-dependent) diabetes mellitus in elderly subjects
17. Glucose tolerance and blood pressure; long term follow up in middle aged men
18. Is insulin an independent risk factor for hypertension? The Paris Prospective Study
19. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population; the Paris Prospective Study, 15-year follow-up
20. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
21. Development of a type 2 diabetes symptom checklist; a measure of symptom severity
22. Microalbuminuria in a random cohort of recently diagnosed type 2 (non- insulin-dependent) diabetic patients living in the greater Munich area
23. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis
24. UK Prospective Diabetes Study (UKPDS) Group
25. UK Prospective Diabetes Study Group
26. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
27. Characterization of the prediabetic state